Growth Metrics

Biogen (BIIB) Other Working Capital Changes (2016 - 2025)

Biogen (BIIB) has 17 years of Other Working Capital Changes data on record, last reported at -$119.3 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 217.29% year-over-year to -$119.3 million; the TTM value through Dec 2025 reached $60.6 million, up 115.66%, while the annual FY2025 figure was $60.6 million, 115.66% up from the prior year.
  • Other Working Capital Changes reached -$119.3 million in Q4 2025 per BIIB's latest filing, down from $104.4 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $213.6 million in Q1 2022 and bottomed at -$149.9 million in Q3 2022.
  • Average Other Working Capital Changes over 5 years is $5.6 million, with a median of $16.2 million recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: surged 537.3% in 2021, then crashed 1445.36% in 2022.
  • A 5-year view of Other Working Capital Changes shows it stood at -$88.8 million in 2021, then soared by 139.3% to $34.9 million in 2022, then tumbled by 291.4% to -$66.8 million in 2023, then surged by 43.71% to -$37.6 million in 2024, then plummeted by 217.29% to -$119.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$119.3 million in Q4 2025, $104.4 million in Q3 2025, and $22.0 million in Q2 2025.